|
|
Date of Entry
|
| 3293 |
Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service EJHP |
12/03/2012 |
| 3285 |
Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method. Yakugaku Zasshi |
26/02/2012 |
| 3279 |
A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care. J Clin Pharm Ther |
02/02/2012 |
| 3269 |
Stability of an extemporaneously prepared thalidomide suspension. Am J Health-Syst Pharm |
13/01/2012 |
| 3274 |
Stability of sildenafil (Revatio®) dolutions in dextrose 5%. Intensice Care Medecine |
13/01/2012 |
| 3266 |
In Use stability of dacarbazine solutions. Lipomed |
03/01/2012 |
| 3267 |
Dacarbazine Lipomed - Summary of Product Characteristics Lipomed |
03/01/2012 |
| 3264 |
Nalbuphine stability at 1 mg/mL concentration. AAPS Congress - Washington, October 2011 |
29/12/2011 |
| 3265 |
Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène. SFPO Congress, France |
29/12/2011 |
| 3263 |
Stability of buffered lidocaine in glass vials. Can J Hosp Pharm |
27/12/2011 |
| 3262 |
Conditions causing gemcitabine crystallization. J Oncol Pharm Practice |
26/12/2011 |
| 3254 |
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm |
14/12/2011 |
| 3255 |
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment Ann Pharm Fr |
14/12/2011 |
| 3256 |
Stability of Hospira filgrastim following changes to thermal and photic storage conditions. EJHP |
14/12/2011 |
| 3258 |
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags. Int J Pharm Compound |
14/12/2011 |
| 3260 |
Vibativ® (telavancin) - Summary of Products characteristics Astellas Pharma Europe |
14/12/2011 |
| 3249 |
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm |
25/11/2011 |
| 3250 |
Eribulin (Halaven) Summary of Product Characteristics. Eisai Ltd |
25/11/2011 |
| 3246 |
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C. SFPO Congress Mandelieu, France |
18/11/2011 |
| 3240 |
Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène. Congrès SFPO |
07/11/2011 |
| 3241 |
Physicochemical and biological stability of diluted rituximab solutions stored 6 months at 4°C. ECCO Congress Stockholm |
07/11/2011 |
| 3243 |
Stability of diluted L-asparaginase in normal saline solution. ECCO Congress Stockholm |
07/11/2011 |
| 3237 |
Jevtana® Résumé des caractéristiques du produit. Sanofi Aventis France |
18/09/2011 |
| 3236 |
Vidaza® Résumé des caractéristiques du produit (France) Celgene |
09/09/2011 |
| 3228 |
Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers Am J Health-Syst Pharm |
05/09/2011 |
| 3229 |
Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes Am J Health-Syst Pharm |
05/09/2011 |
| 3230 |
Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags Can J Hosp Pharm |
05/09/2011 |
| 3231 |
Stability of Ciprofloxacin in Polyvinylchloride Minibags. Can J Hosp Pharm |
05/09/2011 |
| 3235 |
Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen. ADKA Congress 2011 |
05/09/2011 |
| 3224 |
The stability of soluble insulin in plastic syringes EJHP Science |
17/08/2011 |
